MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer

By sjmartinez • October 11, 2023

Crowell PD, Giafaglione JM, Jones AE, Nunley NM, Hashimoto T, Delcourt AML, Petcherski A, Agrawal R, Bernard MJ, Diaz JA, Heering KY, Huang RR, Low JY, Matulionis N, Navone NM, Ye H, Zoubeidi A, Christofk HR, Rettig MB, Reiter RE, Haffner MC, Boutros PC, Shirihai OS, Divakaruni AS, Goldstein AS. MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer. Cell Rep. 2023 Oct 9;42(10):113221. doi: 10.1016/j.celrep.2023.113221. Epub ahead of print. PMID: 37815914.

Tags: Cancer, CP, Endocrinology, Metabolism, Publications

Targeting insulin stacking to address overnight hypoglycaemia in hospitalised patients with diabetes

Moolchandani P, Patel S, Larsen T, Moriates C, Weinreb J, Everett E. Targeting insulin stacking to address overnight hypoglycaemia in hospitalised patients with diabetes. BMJ[...]

Workshop Report-Heterogeneity and Successful Aging Part I: Heterogeneity in Aging-Challenges and Opportunities

Kuchel GA, Hevener AL, Ruby JG, Sebastiani P, Kumar V. Workshop Report-Heterogeneity and Successful Aging Part I: Heterogeneity in Aging-Challenges and Opportunities. J Gerontol A[...]

Identification of Wnt-5a Receptors Important in Diabetic and Non-Diabetic Corneal Epithelial Wound Healing

Shah R, Amador C, Poe AJ, Spektor TM, Bhandary P, Wang Y, Wang ZP, Weisenberger DJ, Borges VF, Sawant OB, Maguen E, Hamrah P, Kramerov[...]